Entered into an exclusive license agreement with Dynavax for the Company’s COVID-19 oral pill vaccine candidate for potential cumulative proceeds ...
Vaxart Inc (VXRT) announces a major partnership with Dynavax and reports significant revenue growth, while navigating market ...
Entered into an exclusive license agreement with Dynavax for the Company's COVID-19 oral pill vaccine candidate for potential cumulative proceeds of up to $700 million plus royalties Completed enrollm ...
From providing accurate COVID-19 information to advocating for testing and vaccination with cultural sensitivity, these ...
With continued investment in mRNA research, Donald Trump could turn the stalemate against cancer into a decisive breakthrough ...
Q3 earnings beat estimates but pipeline setback and lower 2025 guidance raise concerns. Full analysis of results and outlook.
Bengaluru: With healthcare systems worldwide struggling to balance mounting costs and increasingly complex patient needs, ...
Live Science on MSN
Science history: 'Patient zero' catches SARS, the older cousin of COVID — Nov. 16, 2002
A person came down with an atypical form of pneumonia in November 2002, but it would be two months before anyone realized it ...
1don MSN
Vaxart extends cash runway into Q2 2027 with Dynavax partnership and targets 2026 data readouts
Q3 2025 Management View CEO Steven Lo announced a major partnership with Dynavax, under which Vaxart could receive up to $700 million in license, regulatory, and milestone fees, as well as royalties ...
In a societal context, social stress describes the shared emotional pressure that spreads through networks, shaping public mood, cohesion and behaviour.
Researchers say the new treatment holds the potential to treat some dogs diagnosed with cancer without turning to more ...
MINNEAPOLIS (AP) — Attorneys in the case of a man charged with killing a top Minnesota Democratic lawmaker and her husband ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results